Soft­Bank's newest, $165M biotech in­vest­ment looks for in­fec­tious traces in the blood

Soft­Bank has found its newest biotech in­vest­ment.

The Japan­ese bank has in­vest­ed $165 mil­lion in­to Kar­ius, a com­pa­ny that us­es blood tests to di­ag­nose in­fec­tious …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER